Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Pharmaceutics|March 6, 2021
Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ EvaluationBasanth Babu Eedara, Dinesh Nyavanandi, Sagar Narala, et al.
Pharmaceutics|September 23, 2022
Nose-to-Brain Delivery of Therapeutic Peptides as Nasal AerosolsWafaa Alabsi, Basanth Babu Eedara, David Encinas-Basurto, et al.
AAPS Pharmscitech|June 18, 2021
Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and PeptidesBasanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 8, 2015
Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluationSpandana Inugala, Basanth Babu Eedara, Sharath Sunkavalli, et al.
International Journal of Pharmaceutics|September 13, 2019
Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosisBhamini Rangnekar, Mohammad A M Momin, Basanth Babu Eedara, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 7, 2018
Development and characterization of high payload combination dry powders of anti-tubercular drugs for treating pulmonary tuberculosisBasanth Babu Eedara, Bhamini Rangnekar, Shubhra Sinha, et al.
Pharmaceutics|August 10, 2021
Inhalation Delivery for the Treatment and Prevention of COVID-19 InfectionBasanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 21, 2019
Crystalline adduct of moxifloxacin with trans-cinnamic acid to reduce the aqueous solubility and dissolution rate for improved residence time in the lungsBasanth Babu Eedara, Ian G Tucker, Zoran D Zujovic, et al.
International Journal of Pharmaceutics|March 10, 2024
Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosisClaire Fan, Basanth Babu Eedara, Shubhra Sinha, et al.
RSC Advances|September 17, 2024
Design and comprehensive characterization of dry powder inhalation aerosols of simvastatin DPPC/DPPG lung surfactant-mimic nanoparticles/microparticles for pulmonary nanomedicineDavid Encinas-Basurto, Maria F Acosta, Basanth Babu Eedara, et al.
Pageof 3